维普期刊资源整合服务平台（V6.5）

61篇 您的检索式：作者名="WADLER S"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Fluorouracil and recombinant alfa-2a-interferon:an active regimen against advanced colorectal carcinoma显示文摘	Wadler S Schwartz EL Goldman M	1989	J Clin Oncol1989，7，：	1
2	Thymidine phosphorylase mediates the sensitivity of human colon-carcinoma cells to 5-fluorouracil显示文摘	Schwartz EL Baptiste N Wadler S	1995	J Biol Chem1995，270，19：	1
3	Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies:a review显示文摘	Wadler S Schwartz EL	1990	Cancer Res1990，50，：	1
4	Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5 - fluorouracil显示文摘	Schwartz EL Baptiste N Wadler S	1995	J Biol Chem1995，270，：	1
5	Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: A review 显示文摘	Wadler S Schwartz EL	1990	Cancer Res1990，50，12：	1
6	Phase Ⅰ and pharmacokinetic study of the ribonucleotide reductase inhibitor,3-aminopyridine-2-carboxaldehyde thiosemicarbazone,administered by 96-hour intravenous continuous infusion显示文摘	Makower D Clairmont C	2004	J Clin Oncol2004，22，9：	1
7	Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malig- nancies : a review显示文摘	Wadler S Schwartz E L	1990	Cancer Res1990，50，12：	1
8	Fluorouracil and recombinant alfa-2a-interferon:an active regimen against advanced colorectal carcinoma显示文摘	Wadler S Schwartz EL Goldman M		0，，12：	1
9	Thymidine phosphorylase mexliates the scasitivity of human colon carcimona celle to 5-fluorouracil显示文摘	Schwartz EL Baptistc N Wadler S	1995	J Biol Chem1995，270，19：	1
10	Sequential phaselI trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced coloreetal carcinoma显示文摘	WADLER S HAYNES H ROZENBLIT A	1998	Cancer J Sci Am1998，4，5：	1
11	Management of hypocalcemic effectsof WR2721administered onadaily times five schedule with eisplatinand radiationtherapy显示文摘	Wadler S Haynes H Beitler J J	1993	J ClinOncol1993，11，8：	1
12	A pilot study of edrecolomab(Panorex, 17- 1A antibody)and capecitabine in patients with advanced or metastatic adenocarcinom a显示文摘	MaKower D Sparano JA Wadler S	2003	Cancer Invest2003，21，2：	1
13	A pilot study of edrecolomab and capcitabine in patients with advanced or metastatic adenocarcinoma显示文摘	Makuwer D Sparano JA Wadler S	2003	Cancer Investig2003，21，2：	1
14	Result of two randomized trials compring nolatrexed (thymitaqTM) versus methotrexate in patients with recurrent head and neck cancer 显示文摘	Pivot X Wadler S Kelly C	2001	Annals of Oneology2001，12，：	1
15	Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study 显示文摘	Nezhat F Wadler S Muggia F	2004	Gynecol Oncol2004，93，：	1
16	Endocrine-mediated mechanisms of fatigue during treatment with interferon-alpha显示文摘	Jones T H Wadler S Hupart K H	1998	Semin Oncol1998，25，：	1
17	Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo 显示文摘	Makower D Wadler S Haynes H	1997	Clin Cancer Res1997，3，6：	1
18	Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma:eastern cooperative oncology group study E3E93显示文摘	Wadler S Levy DE Lincoln ST	2003	J Clin Oncol2003，21，11：	1
19	New developments in treatment of ovarian cancer 显示文摘	Wadler S	2001	Expert Opin Investig Drugs2001，10，6：	1
20	The role of interferons in the treatment of solid tumors显示文摘	Wadler S	1991	Cancer1991，704，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示